GleamWall
中文EN

DNA Ginkgo Bioworks Holdings, Inc.

Biological Products, (No Diagnostic Substances) · NYSE · SEC CIK 1830214 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-33.1%
TTM net income YoY26.1%
TTM EPS YoY—
Revenue 3-yr CAGR-31.6%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-242.5%
Net margin-249.2%
FCF margin-172.3%
EBITDA margin-190.5%

Returns

ROE-52.7%
ROA-23.5%
ROIC (approx.)-51.0%
Asset turnover0.09x

Leverage & solvency

Liabilities / assets58.4%
Debt / equity0.00x
Current ratio4.72x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.67x
Accruals ratio-7.9%
Payout ratio—
Capex / revenue6.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$170.16M$227.04M
R&D expense$243.77M$424.06M
SG&A expense$183.29M$246.16M
Operating income-$315.28M-$559.76M
Interest expense$0$94,000
Pretax income-$313.60M-$547.51M
Income tax-$837,000-$479,000
Net income-$312.76M-$547.03M
EBITDA-$256.29M-$496.74M
EPS (basic)-5.64-10.54
EPS (diluted)-5.64-10.54
Weighted avg. shares (diluted)55.46M51.89M
Banking
Loans, net$9.70M$25.10M
Balance sheet
Cash & equivalents$167.20M$561.57M
Short-term investments$255.42M$0
Receivables$24.03M$21.86M
Current assets$471.84M$602.74M
PP&E, net$167.37M$203.72M
Goodwill—$0
Intangibles$53.48M$72.51M
Total assets$1.12B$1.38B
Current liabilities$95.97M$107.27M
Total liabilities$611.11M$661.39M
Shareholders' equity$508.59M$716.06M
Shares outstanding58.21M54.37M
Cash flow statement
Operating cash flow-$171.06M-$319.58M
Capital expenditure$7.67M$62.54M
Free cash flow-$178.72M-$382.13M
Investing cash flow-$240.29M-$62.24M
Financing cash flow$17.77M-$1.74M
Depreciation & amortization$58.99M$63.02M
Stock-based compensation$81.55M$112.34M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.